|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online July 1, 2009
In this issue |
|
The integrin
6β4 – which functions as a cell-surface receptor for laminins of the basement membrane – is expressed predominantly in epithelial cells and in some carcinomas. Despite the role of
6β4 integrin in tumour-cell behaviour, little has been known about how expression of the β4 subunit is regulated. Now, though, Arthur Mercurio and colleagues (p. 2473) explore the role of epigenetic modifications on β4 expression, and show that the β4 promoter (which contains a large CpG island) is unmethylated in mammary-gland basal epithelial cells (which express β4) and methylated in luminal epithelial cells from the same tissue (which do not). In addition, when mammary-gland cells are treated with TGFβ to induce the epithelial-mesenchymal transition (EMT), β4 expression is lost and the promoter is methylated de novo. At the same time, they report, there is a dramatic decrease in the levels of histone modifications that are associated with actively transcribed promoters, and an increase in the level of a repressive histone modification. When TGFβ is withdrawn, β4 expression is restored; interestingly, this involves partial reversal of EMT-induced histone modifications in the promoter, but does not require demethylation. The authors conclude that histone modifications, not methylation status, are the predominant factor in reactivating β4-integrin expression in this context.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
Related articles in JCS:
| ||||||||||||||||||||||||||||||||||||